RLAY - Relay Therapeutics surges 13% on early-stage data on tumors asset
2023-10-12 19:15:54 ET
More on Relay Therapeutics
- Relay Therapeutics: Market May Be Prematurely Dismissing RLY-2608
- Seeking Alpha’s Quant Rating on Relay Therapeutics
- Historical earnings data for Relay Therapeutics
- Financial information for Relay Therapeutics
For further details see:
Relay Therapeutics surges 13% on early-stage data on tumors asset